Two Seas Capital LP has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $5.37 Billion distributed in 45 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Roivant Sciences Ltd. with a value of $119M, Immunovant, Inc. with a value of $62M, Vistra Corp. with a value of $44.8M, Sotera Health CO with a value of $44.7M, and Gannett Co., Inc. with a value of $40.2M.

Examining the 13F form we can see an increase of $2.59B in the current position value, from $2.78B to 5.37B.

Two Seas Capital LP is based out at Rye, NY

Below you can find more details about Two Seas Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $5.37 Billion
ETFs: $4.29 Billion
Technology: $492 Million
Healthcare: $380 Million
Utilities: $62.6 Million
Financial Services: $52.9 Million
Communication Services: $51.3 Million
Energy: $37.5 Million
Industrials: $1.69 Million
Other: $0

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 45
  • Current Value $5.37 Billion
  • Prior Value $2.78 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 13, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 11 stocks
  • Additional Purchases 17 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Two Seas Capital LP Portfolio

Follow Two Seas Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Seas Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Seas Capital LP with notifications on news.